CONVERGING EVIDENCE FROM RODENT AND HUMAN STUDIES ON THE ROLE OF SPIRONOLACTONE AS A POTENTIAL PHARMACOTHERAPY FOR ALCOHOL USE DISORDER

被引：0
|
作者：
Farokhnia, Mehdi
Rentsch, Christopher T.
Chuong, Vicky
McGinn, M. Adrienne
Elvig, Sophie K.
Douglass, Eliza A.
Gonzalez, Luis A.
Sanfilippo, Jenna E.
Marchette, Renata C. N.
Tunstall, Brendan J.
Fiellin, David A.
Koob, George F.
Justice, Amy C.
Leggio, Lorenzo
Vendruscolo, Leandro F.
机构：
来源：
ALCOHOL | 2023年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
S69
引用
收藏
页码：83 / 84
页数：2
相关论文
共 50 条
  • [11] The glucagon-like peptide-1 receptor as a potential treatment target in alcohol use disorder: evidence from human genetic association studies and a mouse model of alcohol dependence
    P Suchankova
    J Yan
    M L Schwandt
    B L Stangl
    E C Caparelli
    R Momenan
    E Jerlhag
    J A Engel
    C A Hodgkinson
    M Egli
    M F Lopez
    H C Becker
    D Goldman
    M Heilig
    V A Ramchandani
    L Leggio
    Translational Psychiatry, 2015, 5 : e583 - e583
  • [12] Acetylcholine Muscarinic M4 Receptors as a Therapeutic Target for Alcohol Use Disorder: Converging Evidence From Humans and Rodents
    Walker, Leigh C.
    Berizzi, Alice E.
    Chen, Nicola A.
    Rueda, Patricia
    Perreau, Victoria M.
    Huckstep, Katherine
    Srisontiyakul, Jirawoot
    Govitrapong, Piyarat
    Jia Xiaojian
    Lindsley, Craig W.
    Jones, Carrie K.
    Riddy, Darren M.
    Christopoulos, Arthur
    Langmead, Christopher J.
    Lawrence, Andrew J.
    BIOLOGICAL PSYCHIATRY, 2020, 88 (12) : 898 - 909
  • [13] The cerebellum and fear extinction: evidence from rodent and human studies
    Doubliez, Alice
    Nio, Enzo
    Senovilla-Sanz, Fernando
    Spatharioti, Vasiliki
    Apps, Richard
    Timmann, Dagmar
    Lawrenson, Charlotte L.
    FRONTIERS IN SYSTEMS NEUROSCIENCE, 2023, 17
  • [14] The potential role of extracellular vesicles in myelin disruption in alcohol use disorder
    Peng, H.
    Nixon, K.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 47 : 162 - 162
  • [15] Reductions in World Health Organization Risk Drinking Level Are Associated With Reductions in Alcohol Use Disorder Diagnosis and Criteria: Evidence From an Alcohol Pharmacotherapy Trial
    Richards, Dylan K.
    Tuchman, Felicia R.
    Hallgren, Kevin A.
    Kranzler, Henry R.
    Aubin, Henri-Jean
    O'Malley, Stephanie S.
    Mann, Karl
    Aldridge, Arnie
    Anton, Raymond F.
    Witkiewitz, Katie
    JOURNAL OF ADDICTION MEDICINE, 2024, 18 (04) : 418 - 424
  • [16] The Anti-Diabetic Potential of Baicalin: Evidence from Rodent Studies
    Szkudelski, Tomasz
    Szkudelska, Katarzyna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (01)
  • [17] Rate of Consumption as a Marker for Alcohol Use Disorder Risk: Evidence From a Human Laboratory Model
    Gowin, Joshua
    Sloan, Matthew
    Stangl, Bethany
    Stoddard, Joel
    Vatsalya, Vatsalya
    Ramchandani, Vijay
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S266 - S267
  • [18] Glutamatergic Dysfunction and Synaptic Ultrastructural Alterations in Schizophrenia and Autism Spectrum Disorder: Evidence from Human and Rodent Studies
    Eltokhi, Ahmed
    Santuy, Andrea
    Merchan-Perez, Angel
    Sprengel, Rolf
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (01) : 1 - 26
  • [19] Alcohol Tolerance in Human Laboratory Studies for Development of Medications to treat Alcohol Use Disorder
    Haass-Koffler, Carolina L.
    Perciballi, Roberta
    ALCOHOL AND ALCOHOLISM, 2020, 55 (02): : 129 - 135
  • [20] The Ghrelin System as a Potential Target for Treatment of Alcohol Use Disorder: Pharmacological Evidence
    Richardson, Rani
    Koob, George
    Vendruscolo, Leandro
    Leggio, Lorenzo
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 480 - 481
12345